Sanara MedTech Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Seth D. Yon
- Full Time Employees
- 108
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 1200 Summit Avenue Fort Worth TX United States of America 76102
- IPO Date
- Apr 7, 1994
- CIK
- 0000714256
- Website
- sanaramedtech.com
- Similar Companies
- Business
- Sanara MedTech Inc. (NASDAQ: SMTI), a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings primarily in the United States. Founded in 2001 and headquartered in Fort Worth, Texas, the company offers CellerateRX Surgical Activated Collagen Powder, a hydrolyzed Type I bovine collagen for surgical, traumatic, and burn wounds; BIASURGE Advanced Surgical Solution, a no-rinse antimicrobial irrigation solution; FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, both porcine small intestinal submucosa-based products for soft tissue reinforcement; TEXAGEN Amniotic Membrane Allograft, a multilayer barrier for wounds; ALLOCYTE Plus Advanced Viable Bone Matrix, a cellular bone allograft; BiFORM Bioactive Moldable Matrix, an osteoconductive bone graft; ACTIGEN Verified Inductive Bone Matrix, a differentiated allograft; BIAKŌS Antimicrobial Skin and Wound Cleanser, Gel, and Irrigation Solution; and HYCOL Hydrolyzed Collagen for chronic wound care. Sanara MedTech recently secures a $55 million non-dilutive debt facility from CRG Servicing LLC in April 2024 to fund growth initiatives, permitted acquisitions, and working capital, with $15 million drawn initially and up to $40 million more available through June 2025; enters an exclusive U.S. distribution agreement with InfuSystem Holdings Inc. for ChemoMouthpiece oral cryotherapy device in September 2024, accompanied by a $5 million investment for 6.6% ownership to expand skincare offerings for oncology patients; and reports third-quarter 2025 net revenue of $26.3 million, up 22% from the prior year, alongside expansions into virtual wound and skin care telemedicine services.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Sanara MedTech: From Cash Burner To Profitable Growth
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Sanara MedTech Inc. (SMTI) Q1 2026 Earnings Call Transcript
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
White Brook Capital Partners: Stocks We Believe Will Be Meaningful Contributors
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI)
Sanara MedTech Inc. (SMTI) Q4 2025 Earnings Call Transcript